A detailed history of Bank Of America Corp transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 217,645 shares of SENS stock, worth $69,646. This represents 0.0% of its overall portfolio holdings.

Number of Shares
217,645
Previous 248,475 12.41%
Holding current value
$69,646
Previous $99,000 23.23%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.32 - $0.49 $9,865 - $15,106
-30,830 Reduced 12.41%
217,645 $76,000
Q2 2024

Aug 14, 2024

BUY
$0.37 - $0.52 $5,453 - $7,664
14,739 Added 6.31%
248,475 $99,000
Q1 2024

May 15, 2024

SELL
$0.5 - $0.73 $147 - $215
-295 Reduced 0.13%
233,736 $123,000
Q4 2023

Feb 14, 2024

SELL
$0.48 - $0.7 $46,044 - $67,148
-95,926 Reduced 29.07%
234,031 $133,000
Q2 2023

Aug 14, 2023

SELL
$0.55 - $0.89 $25,927 - $41,954
-47,140 Reduced 12.5%
329,957 $250,000
Q1 2023

May 12, 2023

SELL
$0.68 - $1.25 $13,085 - $24,053
-19,243 Reduced 4.86%
377,097 $267,000
Q4 2022

Feb 10, 2023

BUY
$0.96 - $1.34 $147,853 - $206,378
154,014 Added 63.56%
396,340 $408,000
Q3 2022

Nov 14, 2022

SELL
$1.02 - $2.23 $223,861 - $489,422
-219,472 Reduced 47.53%
242,326 $319,000
Q2 2022

Aug 12, 2022

SELL
$0.94 - $1.94 $1.36 Million - $2.81 Million
-1,450,616 Reduced 75.85%
461,798 $475,000
Q1 2022

May 16, 2022

BUY
$1.54 - $3.71 $2.43 Million - $5.85 Million
1,575,913 Added 468.32%
1,912,414 $3.77 Million
Q4 2021

Feb 08, 2022

BUY
$2.58 - $3.91 $591,103 - $895,820
229,110 Added 213.34%
336,501 $898,000
Q3 2021

Nov 15, 2021

BUY
$2.77 - $4.05 $122,204 - $178,673
44,117 Added 69.72%
107,391 $365,000
Q2 2021

Sep 13, 2021

BUY
$1.71 - $4.14 $108,198 - $261,954
63,274 New
63,274 $243,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $149M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.